CG Oncology, Inc. (CGON) Misses Q2 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts CGON Hot Sheet
Join SI Premium – FREE
CG Oncology, Inc. (NASDAQ: CGON) reported Q2 EPS of ($0.90), $0.30 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura flags this tech pocket as 'portfolio shelter' from AI spending pressure
- Fox Advisors Upgrades Plexus (PLXS) to Overweight
- Intrepid Potash (IPI) PT Lowered to $41 at Freedom Broker
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
